Priscilla Kelly

Priscilla Kelly has extensive experience in the field of oncology and cancer research, currently serving as a Senior Editor at Science Magazine since January 2016, with a focus on oncology, cancer immunotherapy, translational immunology, COVID-19, and clinical trials. Prior to this role, Priscilla worked as a Scientist at The National Institutes of Health from 2012 to 2016, where responsibilities included the development of IRAK4 kinase inhibitors and other small molecules aimed at treating blood cancers and autoimmune disorders, as well as leading in vivo pharmacology for industry-partnered drug development programs. Priscilla holds a Bachelor of Science with First Class Honors in Molecular Genetics and Microbiology from The University of Western Australia and a Doctor of Philosophy in Cancer Immunology from the University of Melbourne.